Conformational analysis reveals membrane topology of M2e in influenza A, suggesting potential for monoclonal antibodies.
The N-terminal ectodomain of influenza A M2 protein exhibits high sequence conservation across strains and is a target for universal influenza vaccine development. M2 is a 97-amino-acid membrane-bound protein that consists of an N-terminal ectodomain (M2e, residues 1-21), a transmembrane domain (residues 22-47), and a C-terminal cytoplasmic domain (residues 47-97). Despite its significance, many structural studies of the M2 protein have not included M2e in their analyses. The therapeutic potential of monoclonal antibodies against M2e has been explored; yet, there is limited atomic level detail on M2e-antibody complexes. Our work uses full-length M2 protein embedded in lipid bilayer membrane nanodiscs both with and without antibody present. Characterization methods include size-exclusion chromatography, dynamic light scattering, biolayer interferometry, and electron microscopy. Using site-directed spin labeling electron paramagnetic resonance spectroscopy we examined the conformation, dynamics, and membrane topology of sites along M2e. Results are consistent with a region that can adopt multiple conformations, including a population that has a turn in the middle of the ectodomain whose proximity to the membrane surface is sensitive to membrane composition.
No takes yet. Share an insight, caveat, or question.
Ghil et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: